China Resources Pharmaceutical Group Limited reported that, effective 13 July 2026, Mr. Guo Chuan has stepped down from his position as non-executive director citing other work commitments. The company confirmed that Mr. Guo has no disagreements with the Board and no matters need to be brought to shareholders’ attention. The Board expressed appreciation for his contributions during his tenure.

Concurrently, the Board appointed Mdm. Zhang Jing, aged 57, as a non-executive director with effect from the same date. Zhang’s public-sector experience spans over two decades, including senior roles at the Beijing Municipal Finance Bureau and the State-owned Assets Supervision and Administration Commission of Beijing Municipality. Since September 2023, she has served as chief accountant at Beijing State-owned Capital Operation and Management Company Limited. She holds a Master’s degree in Project Management from a joint programme between Tianjin University of Technology and the University of Quebec at Chicoutimi and carries the professional title of Senior Accountant.

Zhang enters the Board without a fixed-term service contract and will be subject to retirement by rotation and re-election in accordance with the company’s articles of association. She will not receive director’s emoluments and holds no shares in the company or its associated corporations. The company confirmed she maintains no relationships with existing directors, senior management, or substantial shareholders and has not served as a director of any other listed companies in the past three years.

Following these changes, the Board now comprises one chairman/executive director, two additional executive directors, five non-executive directors, and four independent non-executive directors.